Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/03/184
Active ingredient: Cilengitide
Indication: Treatment of glioma
Sponsor: Merck KGaA
Frankfurter Straße 250, D-64293 Darmstadt, Deutschland

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2004 Centralised Orphan - Designation EMEA/OD/067/03 (2003)97 of 14/01/2004
12/03/2013 Centralised Orphan - Removal of orphan designation from Community Register